MNOV Gross Margin

The Gross Margin of MediciNova Inc (MNOV) is 7.58%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

MNOV Gross Margin - Historical Value

Date	Value
2025-12-31	7.58%

MNOV Gross Margin - Peers Comparison

Ticker	Name	Value
UBX	Unity Biotechnology Inc	7775.20%
IBIO	iBio Inc	38.40%
IMNM	Immunome, Inc.	7775.20%
IMUX	Immunic, Inc.	7775.20%
KZR	Kezar Life Sciences, Inc.	7775.20%
MDNA.TO	Medicenna Therapeutics Corp	7775.20%
MTCR	Metacrine Inc	7775.20%
OVID	Ovid Therapeutics Inc.	7775.20%
GRCL	Gracell Biotechnologies Inc	7775.20%
ONCS	OncoSec Medical Inc	7775.20%
SVA.V	Sernova Corp	44.44%
950200.KQ	Psomagen Inc	24.48%
CKPT	Checkpoint Therapeutics Inc	7775.20%
GNPX	Genprex Inc	7775.20%
MRNA	Moderna, Inc.	70.32%
REGN	Regeneron Pharmaceuticals, Inc.	86.56%
AMGN	Amgen Inc	70.78%
BIVI	BioVie Inc	7775.20%
RCAR	RenovaCare Inc	-
ABBV	AbbVie Inc.	71.62%
AVEO	Aveo Pharmaceuticals Inc	88.80%
IFRX	InflaRx NV	-24678.79%
LTRN	Lantern Pharma Inc	7775.20%
950160.KQ	Kolon TissueGene Inc	13.28%
950220.KQ	Neoimmunetech Inc	7775.20%
CABA	Cabaletta Bio, Inc.	7775.20%
LRMR	Larimar Therapeutics, Inc.	7775.20%
MRKR	Marker Therapeutics Inc	7775.20%
RVX.TO	Resverlogix Corp	7775.20%
GRTX	Galera Therapeutics Inc	7775.20%
TRVN	Trevena Inc	46.56%
VRTX	Vertex Pharmaceuticals Incorporated	86.24%
EIGR	Eiger BioPharmaceuticals Inc	99.90%
GILD	Gilead Sciences, Inc.	78.84%
VINC	Vincerx Pharma Inc	7775.20%